Home » Arch Therapeutics Issued Notice of Allowance for AC5 Surgical Hemostatic Device
Arch Therapeutics Issued Notice of Allowance for AC5 Surgical Hemostatic Device
Arch Therapeutics has announced that the U.S. Patent and Trademark Office has issued a notice of allowance related to the company’s AC5 surgical hemostatic device.
The broad-method-of-use patent covers technology for treating damaged extracellular matrix and leaky tight junctions.
The Framingham, Mass.-based company now has received patent allowances from the U.S., Japan, Europe, Canada, Israel, Australia, Hong Kong and China. — Anisa Jibrell
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May